Title of Collaborative Activity: |
Federal Interagency Working Group for Diabetes |
Description of Collaborative Activity: |
One of three Federal Interagency Working Groups formed as part of the National Action Plan to Prevent Adverse Drug Events. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
Year the Collaborative Activity Originated: |
2016 |
NIH Participating Institutes/Centers/Office of the Director: |
NIA |
HHS Agency Collaborators on this Activity: |
FDA |
